Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-29

Clinical Trial Update: Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial comparing metformin and pioglitazone for regulating menstrual irregularities and hyperandrogenism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)
  • metformin (metformin)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Menstrual Irregularities, Hyperandrogenism | Phase 1, Phase 2 | Status: UNKNOWN